European Journal of Cancer
Volume 45, Issue 6 , Pages 1042-1066 , April 2009

Survival trends in European cancer patients diagnosed from 1988 to 1999

  • Arduino Verdecchia

      Affiliations

    • National Centre of Epidemiology, Surveillance and Health Promotion, Istituto Superiore di Sanità, Viale Regina Elena 299, I-00161 Roma, Italy
    • ,
  • Stefano Guzzinati

      Affiliations

    • Veneto Tumour Registry, Istituto Oncologico Veneto, I.R.C.C.S. Padova, Italy
    • ,
  • Silvia Francisci

      Affiliations

    • National Centre of Epidemiology, Surveillance and Health Promotion, Istituto Superiore di Sanità, Viale Regina Elena 299, I-00161 Roma, Italy
    • ,
  • Roberta De Angelis

      Affiliations

    • National Centre of Epidemiology, Surveillance and Health Promotion, Istituto Superiore di Sanità, Viale Regina Elena 299, I-00161 Roma, Italy
    • Corresponding Author InformationCorresponding author: Tel.: +39 06 49904283; fax: +39 06 49904285.
    • ,
  • Freddie Bray

      Affiliations

    • Department of Clinical and Registry-Based Research, The Cancer Registry of Norway, Montebello, Oslo, Norway
    • ,
  • Claudia Allemani

      Affiliations

    • Department of Preventive and Predictive Medicine, Istituto Nazionale Tumori, Via Venezian 8, I-20133 Milano, Italy
    • ,
  • Andrea Tavilla

      Affiliations

    • National Centre of Epidemiology, Surveillance and Health Promotion, Istituto Superiore di Sanità, Viale Regina Elena 299, I-00161 Roma, Italy
    • ,
  • Mariano Santaquilani

      Affiliations

    • National Centre of Epidemiology, Surveillance and Health Promotion, Istituto Superiore di Sanità, Viale Regina Elena 299, I-00161 Roma, Italy
    • Department of Preventive and Predictive Medicine, Istituto Nazionale Tumori, Via Venezian 8, I-20133 Milano, Italy
    • ,
  • Milena Sant

      Affiliations

    • Department of Preventive and Predictive Medicine, Istituto Nazionale Tumori, Via Venezian 8, I-20133 Milano, Italy
    • ,
  • the EUROCARE Working Group

Received 1 July 2008 ,Revised 11 November 2008 ,Accepted 12 November 2008.

References 

  1. In:  Estève J,  De Angelis G,  Verdecchia A editor. Trends in cancer survival probability in Europe over the period 1978–1989.  Berrino F,  Capocaccia R,  Estève J, et al. editor. Survival of cancer patients in Europe: the EUROCARE-2 study (IARC scientific publications no. 151). Lyon: International Agency for Research on Cancer; 1999;
  2. Verdecchia A, Francisci S, Brenner H, et al. Recent cancer survival in Europe: a 2000–2002 period analysis. Lancet Oncol. 2007;8:784–796
  3. De Angelis R, Francisci S, Baili P, et al. the EUROCARE Working Group The EUROCARE-4 database of cancer survival in Europe: Data standardization, quality control and methods of statistical analysis. Eur J Cancer. 2009;45:909–930
  4. Corazziari I, Quinn M, Capocaccia R. Standard cancer population for estimating age standardized survival ratios. Eur J Cancer. 2004;40:2307–2316
  5. Der Simonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–188
  6. Berrino F, Capocaccia R, Coleman MP, et al., editors. Survival of cancer patients in Europe. The EUROCARE-3 study. Ann Oncol 2003;14(Suppl. 5):v9–155.
  7. Tomomi M, Qiu D. Comparison of time trends in stomach cancer incidence (1973–1997) in East Asia, Europe and USA, from cancer incidence in five continents, vol. IV–VIII. J Clin Oncol. 2007;37:242–243
  8. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. IARC cancer base no. 5 (version 2.0). Lyon: IARC Press; 2004;
  9. Verdecchia A, Corazziari I, Gatta G, Lisi D, Faivre J, Forman D. Explaining gastric cancer survival differences among European countries. Int J Cancer. 2004;109:737–741
  10. Ramos-De la Medina A, Salgado-Nesme N, Torres-Villalobos G, Medina-Franco H. Clinicopathologic characteristics of gastric cancer in a young patient population. J Gastrointest Surg. 2004;8:240–244
  11. Roy P, Piard F, Dusserre-Guion L, Martin L, Michiels-Marzais D, Faivre J. Prognostic comparison of the pathological classifications of gastric cancer: a population-based study. Histopathology. 1998;33:304–310
  12. Field K, Michael M, Leong T. Locally advanced and metastatic gastric cancer: current management and new treatment developments. Drugs. 2008;68:299–317
  13.  Verdecchia A,  Micheli A,  Gatta GSurvival of cancer patients in Italy: the ITACARE study. Tumori. 1997;83:1–507
  14. Ramos M, Esteva M, Cabeza E, Campillo C, Llobera J, Aguiló A. Relationship of diagnostic and therapeutic delay with survival in colorectal cancer: a review. Eur J Cancer. 2007;43:2467–2478
  15. Taieb J, Puig PL, Bedenne L. Cetuximab plus FOLFOX-4 for fully resected stage III colon carcinoma: scientific background and the ongoing PETACC-8 trial. Exp Rev Anticancer Ther. 2008;8:183–189
  16. The NHS cancer plan: a plan for investment, a plan for reform. <http://www.dh.gov.uk/>; 2006 [accessed 01.12.2006].
  17. Grosclaude P, Galat JP, Macé-Lesech J, Roumagnac-Machelard M, Mercier M, Robillard J. Differences in treatment and survival rates of non-small-cell lung cancer in three regions of France. Brit J Cancer. 1995;72:1278–1282
  18. Henschke CI, McCauley DI, Yankelevitz DF, et al. Early lung cancer action project: overall design and findings from baseline screening. Lancet. 1999;354:99–105
  19. Veronesi G, Bellomi M, Mulshine JL, et al. Lung cancer screening with low-dose computed tomography: a non-invasive diagnostic protocol for baseline lung nodules. Lung Cancer. 2008;61:340–349
  20. Organisation for economic co-operation and development. OECD health data 2004. 1st ed. Paris: OECD; 2004.
  21. Nakamura H, Haruki T, Adachi Y, Fujioka S, Miwa K, Taniguchi Y. Smoking affects prognosis after lung cancer surgery. Surg Today. 2008;38:227–231
  22. Shapiro S, Coleman EA, Broeders M, et al. Breast cancer screening programmes in 22 countries: current policies, administration and guidelines international breast cancer screening network (IBSN) and the European network of pilot projects for breast cancer screening. Int J Epidemiol. 1998;27:735–742
  23. Paci E, Ponti A, Zappa M, et al. Early diagnosis, not differential treatment, explains better survival in service screening. Eur J Cancer. 2005;41:2728–2734
  24. Deacon J, Evans C, Yule R, et al. Sexual behaviour and smoking as determinants of cervical HPV infection and CIN3 among those infected. A case control study nested within the Manchester cohort. Brit J Cancer. 2000;83:1565–1572
  25. Markman M. Pharmaceutical management of ovarian cancer: current status. Drugs. 2008;68:771–789
  26. Tetsche MS, Dethlefsen C, Pedersen L, Sorensen HT, Norgaard M. The impact of comorbidity and stage on ovarian cancer mortality: a nationwide Danish cohort study. BMC Cancer. 2008;8:31
  27. Kvåle R, Auvinen A, Adami HO, et al. Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries. J Natl Cancer Inst. 2007;19(99):1881–1887
  28. Hankey BF, Feuer EJ, Clegg LX, et al. Cancer surveillance series: interpreting trends in prostate cancer – part I: evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates. J Natl Cancer Inst. 1999;91:1017–1024
  29. Jønler M, Eddy B, Poulsen J. Prostate-specific antigen testing in general practice. A survey among 325 general practitioners in Denmark. Scand J Urol Nephrol. 2005;39:3214–3218
  30. Hochhaus A. Advances in the treatment of haematological malignancies: optimal sequence of CML treatment. Ann Oncol. 2007;18(Suppl. 9):58–63
  31. Abramson JS, Shipp MA. Advances in the biology and therapy of diffuse large B-cell lymphoma: moving toward a molecularly targeted approach. Blood. 2005;106:1164–1174
  32. Mitsiades CS, Hayden PJ, Anderson KC, Richardson PG. From the bench to the bedside: emerging new treatments in multiple myeloma. Best Pract Res Clin Haematol. 2007;20:797–816
  33. Verdecchia A, Baili P, Quaglia A, Kunkler I, Berrino F, Micheli A. Patient survival for all cancers combined as indicator of cancer control in Europe. Eur J Public Health. 2008;18(5):527–532
  34. Berrino F, De Angelis R, Sant M, et al. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995–1999: results of the EUROCARE-4 study. Lancet Oncol. 2007;8:773–793

PII: S0959-8049(08)00927-1

doi: 10.1016/j.ejca.2008.11.029

European Journal of Cancer
Volume 45, Issue 6 , Pages 1042-1066 , April 2009

Article Tools